METHODOLOGY
Participants: ALL survivors attending the Pediatric Cancer
Survivorship Clinic (PCSC) were enrolled after a written informed
consent. The study was performed between July 2016 to November 2017. A
total of 70 survivors of ALL were recruited. The institutional review
board of All India Institute of Medical Sciences(AIIMS), approved the
study protocol. Eligibility criteria included survivors of ALL, aged
6-17 years who had completed treatment and had a documented remission of
atleast 2 years. Exclusion criteria included history of any central
nervous system(CNS) or sensory-motor deficits during treatment,
concurrent neurological or psychiatric disorder not primarily attributed
to ALL or any previous genetic diagnosis with known association with
neurocognitive impairment(eg., Down syndrome).